Comments
Loading...
Santen Pharmaceutical (OTC:SNPHY) Stock, Earnings Estimates, EPS, And Revenue
Santen Pharmaceutical reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 7
EPS
$0.240
Quarterly Revenue
$493.2M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$302.6B
Analyze the earnings history of Santen Pharmaceutical using advanced sorting and filters.
Data brought to you by Benzinga APIs
Santen Pharmaceutical (SNPHY) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Santen Pharmaceutical (SNPHY) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Santen Pharmaceutical (OTCPK:SNPHY) reporting earnings?
Santen Pharmaceutical (SNPHY) is scheduled to report earnings on February 11, 2025. The last reported earnings were for reported on November 7, 2024 for Q2.
What were the latest earnings per share (EPS) for Santen Pharmaceutical (OTCPK:SNPHY)?
The Actual EPS was $0.24, which beat the estimate of $0.00.
What were Santen Pharmaceutical’s (OTCPK:SNPHY) revenues?
The Actual Revenue was $493.2M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.